1. When to Consider Sacral Neuromodulation for Overactive Bladder
SNM may be considered for patients with persistent OAB symptoms despite previous treatment.
Relevant symptoms include:
- Urinary urgency that is difficult to control.
- Frequent daytime urination.
- Nocturia that interrupts sleep.
- Urge urinary incontinence.
- Persistent symptoms despite behavioral therapy and medication.
An OAB diagnosis alone does not establish eligibility for SNM. Patient selection requires an individual clinical assessment of symptom severity, previous treatments, medical history and other possible causes of urinary symptoms.
2. Patient Evaluation and Test Stimulation
The treatment pathway includes an assessment stage before permanent implantation.
For international patients, preliminary medical record reviews can be arranged remotely. Relevant materials include:
- Previous diagnosis and treatment records.
- Urinary symptom history.
- Urodynamic study reports, when available.
- Ultrasound and other relevant imaging.
- Current medication and previous treatment information.
Further in-person evaluation may be required before treatment.
Two-stage treatment process
| Stage | Procedure | Specific details |
|---|---|---|
| Stage 1 | Temporary electrode placement | Electrode positioned near the sacral nerve under local anesthesia |
| Test stimulation | External stimulation | Approximately 2 weeks |
| Placement guidance | Fluoroscopic guidance | Used during temporary electrode placement |
| Procedure duration | Test electrode placement | Approximately 1 hour |
| Stage 2 | Permanent implantation | Considered when test stimulation achieves at least 50% symptom improvement |
During the test phase, a temporary electrode delivers stimulation through an external stimulator. The patient's symptom response is assessed before permanent implantation is considered. Patients who do not achieve the required improvement need further clinical review rather than automatic progression to permanent implantation.
3. Permanent Implantation and Treatment Management
When test stimulation demonstrates sufficient improvement and the clinical team confirms suitability, the permanent neurostimulator is implanted under the skin.
The implanted sacral neuromodulation system delivers electrical stimulation to the sacral nerves. Stimulation parameters can be adjusted through device programming during follow-up care.
The treatment pathway includes:
- Review of test stimulation results.
- Confirmation of suitability for permanent implantation.
- Permanent neurostimulator implantation.
- Initial device programming.
- Follow-up assessment and parameter adjustments when required.
Individual symptom improvement and long-term outcomes vary. Potential complications, including infection, implant-site pain, lead displacement and possible revision surgery, should be discussed during clinical consultation.
4. Available Implantable Neurostimulator Options
Three implantable neurostimulator configurations are listed in our website's treatment information. Their main differences concern battery type, battery life, device weight, volume and charging requirements.
| Feature | G132 | G131 | G134R |
|---|---|---|---|
| Battery type | Non-rechargeable | Non-rechargeable | Rechargeable |
| Battery life | 6–8 years | 8–11 years | 20+ years |
| Weight | 25 g | 35 g | 36 g |
| Volume | Smallest | Medium | Medium |
| Battery capacity | 1850 mAh | 2500 mAh | Not specified |
| Stimulation parameters | 0–10 V / 0–25 mA | 0–10 V / 0–25 mA | 0–10 V / 0–25 mA |
| Charging requirements | No routine charging | No routine charging | Wireless charging approximately every 2–3 months |
| MRI compatibility stated on the website | 1.5T and 3.0T | 1.5T and 3.0T | 1.5T and 3.0T |
Device configuration differences
- G132: The smallest listed volume, a weight of 25 g and a non-rechargeable battery with a stated life of 6–8 years.
- G131: A non-rechargeable configuration weighing 35 g, with a stated battery life of 8–11 years and a capacity of 2500 mAh.
- G134R: A rechargeable configuration weighing 36 g, with a stated battery life of more than 20 years and wireless charging approximately every 2–3 months.
The appropriate configuration depends on the patient's clinical condition, stimulation requirements, lifestyle and preferences. Battery-life figures are published specifications, not guarantees of actual service life. MRI examinations must be assessed against the applicable device labeling and scanning conditions.
5. International Patient Assessment and Follow-Up
Our website describes international patient support covering preliminary assessment, treatment coordination and follow-up.
Remote medical record review
International patients can submit imaging, urodynamic studies and previous medical records for preliminary assessment. The clinical team can review treatment history and determine whether further in-person evaluation is appropriate.
English-language medical communication
English-language medical communication is available for consultations, treatment explanations and care instructions.
Remote programming
After treatment and return to their home country, eligible patients can receive remote device programming support through the clinical service. Availability depends on the implanted system, technical arrangements and applicable local requirements.
Continuous follow-up
Follow-up support includes recovery-related communication, device adjustment when required and annual check-ins. Individual follow-up schedules depend on clinical needs.
6. Clinical Experience and Multidisciplinary Support
The clinical profile presented on our website includes Dr. Zhang Yifei, whose experience and professional background are central to the described SNM treatment program.
Published clinical information includes:
- More than 30 years of experience in urinary control disorders and related clinical practice.
- More than 1,000 SNM procedures performed.
- Experience in urology, neuro-urology and complex urinary dysfunction.
- Leadership of a multidisciplinary team involving urologists, neuro-urologists and rehabilitation specialists.
This multidisciplinary approach supports the assessment of patients with overlapping urinary and neurological conditions, particularly when previous treatment has not provided sufficient symptom relief.
7. Request an Overactive Bladder Treatment Assessment
If you have persistent urinary urgency, frequency or urge incontinence despite previous treatment, submit your available medical records for an initial SNM assessment.
Send your diagnostic reports, urodynamic results, imaging and a brief summary of previous treatments. The clinical team can review the information and advise whether further evaluation for sacral neuromodulation is appropriate.
A remote assessment is preliminary and does not replace an in-person diagnosis or guarantee eligibility for surgery. Individual treatment recommendations depend on clinical findings and the patient's response to evaluation.
Start your medical assessment
Submit your available medical records to the international patient team to request an initial assessment.
Hot Tags: sacral neuromodulation for overactive bladder, China, price, pricelist, quotation, cost, clinician programmer neurostimulator, Indications For Sacral Neuromodulation, sacral nerve stimulation test lead, sacral neuromodulation charger, sacral neuromodulation programmer, tined sacral lead

